Home
About
Product
News
Honor
Contact
Purchasing
Company News
Industry trends
Purchasing information
According to the Metropolitan Metro News, a new report shows that the price of a cancer drug has risen by nearly 1400% in just five years. According to the Wall Street Journal, Lomustine is a drug for treating lymphoma and brain tumors. Its current price is $768, compared with $50 in 2013. The price of the drug rose steadily after it was acquired by NextSource Pharmaceutical Company in 2013. Because there was no alternative drug, some cancer patients had to bear huge drug costs, while some patients stopped taking the drug because they could not afford it. NextSource Chief Executive
2017-12-29
According to the Wall Street Journal, Alex, a professor and architect, said in an interview that he had been seriously ill for a week and a half and kept coughing until his girlfriend gave her a bottle of "Kyoto Nianzi Temple Chuanbei Loquat Cream", and his cough immediately improved.
2018-02-28
Congratulations on the establishment of our website
2017-07-18
Panoramic Analysis of China's Foreign Trade in Medical Devices in 2015
Do you know that some medicines need to be protected from light? If you don't know, just take a look
Aprotinin returns to the market or endangers public life
The 17th World Pharmaceutical Raw Materials China Exhibition
2017-07-21
Fosun Pharmaceuticals acquired 74% equity of Gland74 to build an international platform for preparations
2017-09-20